Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.

Autor: Turgeon RD; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: ricky.turgeon@gmail.com., Zieroth S; University of Manitoba, Winnipeg, Manitoba, Canada., Bewick D; New Brunswick Heart Centre, Saint John, New Brunswick, Canada., Chow CM; Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Clarke B; Libin Cardiovascular Institute, Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada., Cowan S; Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada., Fordyce CB; Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada., Fournier A; Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montréal, Québec, Canada., Gin K; Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada., Gupta A; Trillium Health Partners, University of Toronto, Mississauga, Ontario, Canada., Hardiman S; Cardiac Services British Columbia, Provincial Health Services Authority, Vancouver, British Columbia, Canada., Jackson S; Queen Elizabeth II Health Sciences Center, Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada., Lau B; Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada., Leong-Poi H; Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Mansour S; Department of Medicine, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Québec, Canada., Marelli A; McGill University Health Center, Department of Medicine, McGill University, Montréal, Québec, Canada., Quraishi AR; Queen Elizabeth II Health Sciences Center, Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada., Roifman I; Schulich Heart Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Ruel M; University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Sapp J; Queen Elizabeth II Health Sciences Center, Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada., Singh G; Mazankowski Alberta Hearth Institute, Division of Cardiac Surgery, Departments of Critical Care Medicine and Surgery, University of Alberta, Edmonton, Alberta, Canada., Small G; University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Virani S; Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada., Wood DA; Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada., Krahn A; Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
Jazyk: angličtina
Zdroj: The Canadian journal of cardiology [Can J Cardiol] 2020 Aug; Vol. 36 (8), pp. 1180-1182. Date of Electronic Publication: 2020 Jun 02.
DOI: 10.1016/j.cjca.2020.05.033
Databáze: MEDLINE